353
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Incidence Rate, Pathogens and Economic Burden of Catheter-Related Bloodstream Infection: A Single-Center, Retrospective Case-Control Study

, , , , , , , & show all
Pages 3551-3560 | Received 20 Feb 2023, Accepted 25 May 2023, Published online: 05 Jun 2023

References

  • van der Kooi T, Sax H, Pittet D, et al. Prevention of hospital infections by intervention and training (PROHIBIT): results of a pan-European cluster-randomized multicentre study to reduce central venous catheter-related bloodstream infections. Intensive Care Med. 2018;44(1):48–60.
  • Brown R, Burke D. The hidden cost of catheter related blood stream infections in patients on parenteral nutrition. Clinical Nutrition ESPEN. 2020;36:146–149.
  • Saliba P, Hornero A, Cuervo G, et al. Mortality risk factors among non-ICU patients with nosocomial vascular catheter-related bloodstream infections: a prospective cohort study. J Hospital Infection. 2018;99(1):48–54.
  • Burden S, Hemstock M, Taylor M, et al. The impact of home parenteral nutrition on the burden of disease including morbidity, mortality and rate of hospitalisations. Clinical Nutrition ESPEN. 2018;28:222–227.
  • Foda MA, Khalil GM, Gaddoue IM, Azqul MM. Relation between Health Care Providers Compliance with Central Venous Catheter Care Bundle Elements and The Length of Stay in Cardiac Care Units, National Heart Institute. Egyptian J Community Med. 2018;36(4):654.
  • Zeng C, Wu A, Li L, Jia H. Multi-center prospective study on central line-associated bloodstream infections in 79 ICUs of China. BMC Infect Dis. 2021;21(1):1208.
  • Tacconelli E, Smith G, Hieke K, Lafuma A, Bastide P. Epidemiology, medical outcomes and costs of catheter-related bloodstream infections in intensive care units of four European countries: literature- and registry-based estimates. J Hosp Infect. 2009;72(2):97–103.
  • Al-Shukri RN, Al-Rawajfah OM, Al-Daken L, Al-Busaidi M. ICU-acquired central line-associated bloodstream infection and its associated factors in Oman. Am J Infect Control. 2022;50(9):1026–1031.
  • Al-Rawajfah OM, Cheema J, Hewitt JB, Hweidi IM, Musallam E. Laboratory-confirmed, health care-associated bloodstream infections in Jordan: a matched cost and length of stay study. Am J Infect Control. 2013;41(7):607–611.
  • Stone PW. Economic burden of healthcare-associated infections: an American perspective. Expert Rev Pharmacoecon Outcomes Res. 2009;9(5):417–422.
  • Goudie A, Dynan L, Brady PW, Rettiganti M. Attributable cost and length of stay for central line-associated bloodstream infections. Pediatrics. 2014;133(6):e1525–1532.
  • Wilson MZ, Rafferty C, Deeter D, Comito MA, Hollenbeak CS. Attributable costs of central line-associated bloodstream infections in a pediatric hematology/oncology population. Am J Infect Control. 2014;42(11):1157–1160.
  • Dimick JB, Pelz RK, Consunji R, Swoboda SM, Hendrix CW, Lipsett PA. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg. 2001;136(2):229–234.
  • Blot SI, Depuydt P, Annemans L, et al. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis. 2005;41(11):1591–1598.
  • Leistner R, Hirsemann E, Bloch A, Gastmeier P, Geffers C. Costs and prolonged length of stay of central venous catheter-associated bloodstream infections (CVC BSI): a matched prospective cohort study. Infection. 2014;42(1):31–36.
  • Zanwar S, Jain P, Gokarn A, et al. Antibiotic lock therapy for salvage of tunneled central venous catheters with catheter colonization and catheter-related bloodstream infection. Transpl Infect Dis. 2019;21(1):e13017.
  • Balaji B, Wyawahare M, Poranki R, Madigubba H, Sastry AS. Clinical outcomes of suspected Catheter Related Blood Stream Infection at a tertiary care center in south India. Indian J Med Microbiol. 2021;39(2):188–191.
  • Asad L, Muhammad R. Eliminating Infections in the ICU: CLABSI. Curr Infect Dis Rep. 2015;17(7):35.
  • Horan TC, Cic M, Dudeck MA. CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309–332.
  • Centers for Disease Control and Prevention. Vital Signs: central Line–Associated Blood Stream Infections—United States, 2001, 2008, and 2009. Ann Emerg Med. 2011;60(5):243–248.
  • Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818–829.
  • Gastmeier P, Geffers C, Brandt C, et al. Effectiveness of a nationwide nosocomial infection surveillance system for reducing nosocomial infections. J Hosp Infect. 2006;64(1):16–22.
  • Dudeck MA, Weiner LM, Allen-Bridson K, et al. National Healthcare Safety Network (NHSN) report, data summary for 2012, Device-associated module. Am J Infect Control. 2013;41(12):1148–1166.
  • Chopdekar K, Chande C, Chavan S, et al. Central venous catheter-related blood stream infection rate in critical care units in a tertiary care, teaching hospital in Mumbai. Indian J Med Microbiol. 2011;29(2):169–171.
  • Rabensteiner J, Theiler G, Duettmann W, et al. Detection of central venous catheter‐related bloodstream infections in haematooncological patients. Eur J Clin Invest. 2015;45(8):824–832.
  • Na A, Bednárovská E. Catheter-related Bloodstream Infections: do We Know All of It?. Klinicka onkologie. 2017;30(6):405–411.
  • Ruiz-Giardin JM, Ochoa Chamorro I, Velázquez Ríos L, et al. Blood stream infections associated with central and peripheral venous catheters. BMC Infect Dis. 2019;19(1):841.
  • Surapat B, Montakantikul P, Malathum K, Kiertiburanakul S, Santanirand P, Chindavijak B. Microbial epidemiology and risk factors for relapse in gram-negative bacteria catheter-related bloodstream infection with a pilot prospective study in patients with catheter removal receiving short-duration of antibiotic therapy. BMC Infect Dis. 2020;20(1):604.
  • Stewart S, Robertson C, Pan J, et al. Impact of healthcare-associated infection on length of stay. J Hosp Infect. 2021;114:23–31.
  • Higuera F, Rangel-Frausto MS, Rosenthal VD, et al. Attributable cost and length of stay for patients with central venous catheter-associated bloodstream infection in Mexico City intensive care units: a prospective, matched analysis. Infect Control Hospital Epidemiol. 2007;28(1):31–35.
  • Rosenthal VD, Guzman S, Migone O, Crnich CJ. The attributable cost, length of hospital stay, and mortality of central line-associated bloodstream infection in intensive care departments in Argentina: a prospective, matched analysis. Am J Infect Control. 2003;31(8):475–480.
  • Giraldi G, Montesano M, Sandorfi F, Iachini M, Orsi GB. Excess length of hospital stay due to healthcare acquired infections: methodologies evaluation. Ann Ig. 2019;31(5):507–516.
  • Al-Rawajfah OM, Hewitt JB, Stetzer F, Cheema J. Length of stay and charges associated with health care-acquired bloodstream infections. Am J Infect Control. 2012;40(3):227–232.
  • Warren DK, Quadir WW, Hollenbeak CS, Elward AM, Cox MJ, Fraser VJ. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital. Crit Care Med. 2006;34(8):2084–2089.
  • Laupland KB, Lee H, Gregson DB, Manns BJ. Cost of intensive care unit-acquired bloodstream infections. J Hosp Infect. 2006;63(2):124–132.
  • Wagner J, Schilcher G, Zollner‐Schwetz I, et al. Microbiological screening for earlier detection of central venous catheter–related bloodstream infections. Eur J Clin Invest. 2013;43(9):964–969.